Spanish Red Biotech Pipeline

FUND. PROGRESO Y SALUD

GENYO-13001 / FIMABIS-13009

Type: Biomarkers
Therapeutic area: Autoimmune & Inflammation
Indication: Lupus erythematosus / Allergy
Phase: 2Preclinical Validation, 1R+D
Studies location: Europe